Related references
Note: Only part of the references are listed.Empagliflozin nanoparticles attenuates type2 diabetes induced cognitive impairment via oxidative stress and inflammatory pathway in high fructose diet induced hyperglycemic mice
Tahira Khan et al.
NEUROCHEMISTRY INTERNATIONAL (2021)
Deciphering the Role of WNT Signaling in Metabolic Syndrome-Linked Alzheimer's Disease
Abuzer Ali et al.
MOLECULAR NEUROBIOLOGY (2020)
Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk
Douglas Barthold et al.
PLOS ONE (2020)
Pathophysiology of Thrombosis in Peripheral Artery Disease
Aida Habib et al.
CURRENT VASCULAR PHARMACOLOGY (2020)
Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis
Mengshi Zhou et al.
PLOS ONE (2020)
Thrombin, a Mediator of Coagulation, Inflammation, and Neurotoxicity at the Neurovascular Interface: Implications for Alzheimer's Disease
Jaclyn Iannucci et al.
FRONTIERS IN NEUROSCIENCE (2020)
A f3 peptide and fibrinogen weave a web of destruction in cerebral amyloid angiopathy
Woosuk S. Hur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Neuroprotective effects of vildagliptin on drug induced Alzheimer's disease in rats with metabolic syndrome: Role of hippocampal klotho and AKT signaling pathways
Rasha R. Yossef et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends
Moien Abdul Basith Khan et al.
JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2020)
Intrinsic Pathway of Coagulation and Thrombosis: Insights From Animal Models
Steven P. Grover et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Potential of Multidimensional, Large-scale Biodatabases to Elucidate Coagulation and Platelet Pathways as an Approach towards Precision Medicine in Thrombotic Disease
Marina Panova-Noeva et al.
HAMOSTASEOLOGIE (2019)
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Valery L. Feigin et al.
LANCET NEUROLOGY (2019)
Obesity as a Risk Factor for Alzheimer's Disease: Implication of Leptin and Glutamate
Ana Lloret et al.
FRONTIERS IN NEUROSCIENCE (2019)
New therapies using nonfactor products for patients with hemophilia and inhibitors
Keiji Nogami et al.
BLOOD (2019)
Unfolding the pleiotropic facades of rosuvastatin in therapeutic intervention of myriads of neurodegenerative disorders
Ibraheem Husain et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2019)
Rosuvastatin use improvesmeasures of coagulation in patients with venous thrombosis
Joseph S. Biedermann et al.
EUROPEAN HEART JOURNAL (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Rosuvastatin alleviates high-salt and cholesterol diet-induced cognitive impairment in rats via Nrf2-ARE pathway
Ibraheem Husain et al.
REDOX REPORT (2018)
Metabolic Syndrome and Amyloid Accumulation in the Aging Brain
Gabriela Gomez et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review
Blossom C. M. Stephan et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Impact of Metabolic Syndrome on Neuroinflammation and the Blood-Brain Barrier
Peter Van Dyken et al.
FRONTIERS IN NEUROSCIENCE (2018)
Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability
Georgette L. Suidan et al.
BLOOD ADVANCES (2018)
Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease
Boris Decourt et al.
CURRENT ALZHEIMER RESEARCH (2017)
Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration
Eduardo Rojas-Gutierrez et al.
SYNAPSE (2017)
Integrative Analysis to Identify Common Genetic Markers of Metabolic Syndrome, Dementia, and Diabetes
Weihong Zhang et al.
MEDICAL SCIENCE MONITOR (2017)
Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice
Zu-Lin Chen et al.
BLOOD (2017)
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
Katherine Kearney et al.
CARDIOVASCULAR DIABETOLOGY (2017)
High fat diet induces brain insulin resistance and cognitive impairment in mice
Vishal Kothari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Cross Talk Pathways Between Coagulation and Inflammation
Jonathan H. Foley et al.
CIRCULATION RESEARCH (2016)
Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release
Lili Donner et al.
SCIENCE SIGNALING (2016)
A possible new role for Aβ in vascular and inflammatory dysfunction in Alzheimer's disease
Daria Zamolodchikov et al.
THROMBOSIS RESEARCH (2016)
Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia Follow-up of the Singapore Longitudinal Ageing Study Cohort
Tze Pin Ng et al.
JAMA NEUROLOGY (2016)
Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release
Lili Donner et al.
SCIENCE SIGNALING (2016)
Potential effects of vildagliptin on biomarkers associated with prothrombosis in diabetes mellitus
Sana Khan et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease
Xi Chen et al.
LIPIDS IN HEALTH AND DISEASE (2015)
Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration
Marta Cortes-Canteli et al.
NEUROBIOLOGY OF AGING (2015)
Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration
Gertjan van Dijk et al.
FRONTIERS IN NEUROSCIENCE (2015)
Quantitative and Multiplexed Study of Endothelial Cell Inflammation
Jingwen Chai et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Alzheimer's Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions
Anusha Jayaraman et al.
CURRENT DIABETES REPORTS (2014)
Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease
Jaeho Oh et al.
EXPERIMENTAL GERONTOLOGY (2014)
A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice
Hyung Jin Ahn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Tissue plasminogen activator arrests Alzheimer's disease pathogenesis
Shin Bi Oh et al.
NEUROBIOLOGY OF AGING (2014)
Peripheral administration of an anti-TNF-α receptor fusion protein counteracts the amyloid induced elevation of hippocampal TNF-α levels and memory deficits in mice
E. R. Detrait et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Oxidative Stress and Metabolic Syndrome: Cause or Consequence of Alzheimer's Disease?
Diana Luque-Contreras et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective
Verena Wieser et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
The APOE ε4/ε4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients
Karin Hultman et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin
Daria Zamolodchikov et al.
BLOOD (2012)
Contrast-Enhanced Magnetic Resonance Microangiography Reveals Remodeling of the Cerebral Microvasculature in Transgenic ArcAβ Mice
Jan Klohs et al.
JOURNAL OF NEUROSCIENCE (2012)
Genomic Analysis of Reactive Astrogliosis
Jennifer L. Zamanian et al.
JOURNAL OF NEUROSCIENCE (2012)
Insulin in the brain: There and back again
William A. Banks et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
Dimitrios Davalos et al.
NATURE COMMUNICATIONS (2012)
The Prothrombotic Tendency in Metabolic Syndrome: Focus on the Potential Mechanisms Involved in Impaired Haemostasis and Fibrinolytic Balance
Isabella Russo
SCIENTIFICA (2012)
Elevated plasma factor VIII and von Willebrand factor in women with type 2 diabetes: inflammatory reaction, endothelial perturbation or else?
Anna L. Soares et al.
BLOOD COAGULATION & FIBRINOLYSIS (2011)
Cerebrovascular lesions induce transient β-amyloid deposition
Monica Garcia-Alloza et al.
BRAIN (2011)
Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains
Jian-Quan Shi et al.
BRAIN RESEARCH (2011)
Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization
Carson K. Lam et al.
NATURE (2010)
Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's Disease
Marta Cortes-Canteli et al.
NEURON (2010)
Increased Tau Phosphorylation and Cleavage in Mouse Models of Type 1 and Type 2 Diabetes
Bhumsoo Kim et al.
ENDOCRINOLOGY (2009)
Cerebral emboli in the genesis of dementia
Nitin Purandare et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Association between late-life body mass index and dementia The Kame Project
T. F. Hughes et al.
NEUROLOGY (2009)
The metabolic syndrome: progress towards one definition for an epidemic of our time
Paul Zimmet et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study
Ana Verdelho et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease
Justin Paul et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Body mass index in midlife and risk of Alzheimer disease and vascular dementia
Rachel A. Whitmer et al.
CURRENT ALZHEIMER RESEARCH (2007)
Diabetes mellitus and dementia
F. Pasquier et al.
DIABETES & METABOLISM (2006)
Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans
ME Stegenga et al.
DIABETES (2006)
Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia
M van Oijen et al.
STROKE (2005)
Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance
DJ Schneider
CORONARY ARTERY DISEASE (2005)
The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men
SG Wannamethee et al.
ATHEROSCLEROSIS (2005)
Hypercoagulability in the metabolic syndrome
M Nieuwdorp et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
The effects of type 1 diabetes on cognitive performance - A meta-analysis
AMA Brands et al.
DIABETES CARE (2005)
HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women
CJM Doggen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Metabolic Syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study
E Bonora et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation
MC Alessi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey
ES Ford
ATHEROSCLEROSIS (2003)
Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life
GJ Petot et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
The role of insulin resistance in the pathogenesis of Alzheimer's disease - Implications for treatment
GS Watson et al.
CNS DRUGS (2003)
Hypertension and the prothrombotic state
GYH Lip
JOURNAL OF HUMAN HYPERTENSION (2000)
Hyperinsulinemia, hyperglucemia, and impaired hemostasis - The Framingham offspring study
JB Meigs et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
